Chapter 5, Problem 4CS

Please identify the test shown here. 1) What is the test? 2) What does the test indicate? How is it performed? What is CX? 3) Why might the test be performed in a clinical setting? GEN CZ CX CPZ PTZ CAC

Determine how much ATP would a cell produce when using  fermentation of a 50 mM glucose solution?

Determine how much ATP would a cell produce when using aerobic respiration of a 7 mM glucose solution?

Determine how much ATP would a cell produce when using aerobic respiration to degrade one small protein molecule into 12 molecules of malic acid, how many ATP would that cell make? Malic acid is an intermediate in the Krebs cycle. Assume there is no other carbon source and no acetyl-CoA.

Identify each of the major endocrine glands

Come up with a few questions and answers for umbrella species, keystone species, redunant species, and aquatic keystone species

19. On the diagram below a. Label the three pictures as: DNA; polypeptide; or RNA. b. Label the arrows as: translation or transcription/RNA processing. c. Add the following details to the diagram. Promoter region TATA box Transcription start site Transcription terminator Intron (A,B,C,D) Exons (1,2,3,4,5) Splice sites 5' cap 5' UTR (untranslated region) 3' poly A tail 3' UTR (untranslated region) Translational start (AUG) Translational stop (UGA, UAG, or UAA) N and C ends of polypeptide 0000

Match the letter labels in the figure below to the terms. Some letter labels are not used. MNNNNNNIN M C B A M D F E H K G 8

The diagram below illustrates a quorum sensing pathway from Staphylococcus aureus. Please answer the following questions. 1. Autoinduction is part of the quorum sensing system. Which promoter (P2 or P3) is critical for autoinduction? 2)This staphylococcus aureus grows on human wounds, causing severe infections. You would like to start a clinical trial to treat these wound infections. Please describe: a) What molecule do you recommend for the trial. Why? b) Your trial requires that Staphylococcus aureus be isolated from the wound and submitted to genome sequencing before admittance. Why? What are you testing for?  3) If a mutation arises where the Promoter P3 is constitutively active, how would that influence sensitivity to AIP? Please explain your rationale. 4) This pathway is sensitive to bacterial cell density. Describe two separate mutation that would render the pathway active independent of cell density. Briefly explain your rationale. Mutation 1 Mutation 2